ELV · Elevance Health, Inc.
$431.32
-1.96% last session
End-of-day data · close of 2026-10-26
Market cap
$94B
Enterprise value
$86B
Trailing P/E
18.3
Forward P/E
14.2
Dividend yield
2.0%
Beta
0.71
Avg volume
1M
Employees
96K
Daily Change %
-1.96%
5 Days Change
-3.14%
10 Days Change
0.71%
30 Days Change
8.89%
60 Days Change
9.83%
Month to Day Change
13.01%
Year to Day Change
24.84%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ELV
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-23
Latest call per bank · past 12 months
UBS
Buy$523
+21.3% vs priceMorgan Stanley
Equal-Weight$449
+4.1% vs priceRBC Capital
Sector Perform$455
+5.5% vs priceBarclays
Overweight$472
+9.4% vs priceWells Fargo
Overweight$473
+9.7% vs priceJP Morgan
Overweight$476
+10.4% vs priceBank of America
Buy$460
+6.6% vs priceDeutsche Bank
Buy$498
+15.5% vs priceJefferies
Buy$391
-9.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-23 | TD Cowen | Maintains | Buy | $465 → $495 |
| 2026-10-22 | UBS | Maintains | Buy | $460 → $523 |
| 2026-10-22 | Guggenheim | Maintains | Buy | $460 → $485 |
| 2026-10-22 | Morgan Stanley | Maintains | Equal-Weight | $404 → $449 |
| 2026-10-22 | RBC Capital | Maintains | Sector Perform | $424 → $455 |
| 2026-10-22 | Barclays | Maintains | Overweight | $469 → $472 |
| 2026-10-22 | Baird | Maintains | Neutral | $393 → $406 |
| 2026-10-12 | Guggenheim | Maintains | Buy | $455 → $460 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-26
- neutral: RSI (14): RSI is 59 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 5.7% above the 50-day MA ($408.08).
- bullish: Price vs 200-day MA: Trading 16.9% above the 200-day MA ($368.97).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+2.05) — short-term momentum is improving.
- bullish: 52-week range: Price is within 5% of the 52-week high ($445.28).
ELV Price Chart
Loading chart for ELV…
Fundamentals
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
More in Healthcare Plans
UNH
UnitedHealth Group Incorporated
$369B 26.9% YTD
CVS
CVS Health Corporation
$118B 20.2% YTD
CI
The Cigna Group
$81B 13.0% YTD
HUM
Humana Inc.
$50B 64.1% YTD
CNC
Centene Corporation
$34B 65.3% YTD
MOH
Molina Healthcare Inc
$11B 18.0% YTD
OSCR
Oscar Health, Inc.
$10B 116.4% YTD
ALHC
Alignment Healthcare, Inc.
$2B -60.1% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.